The company announced the first cadre of winners in an event at parent company Unilevers R&D centre in Bengaluru. The newly minted fellows – Amrapali Datta, Ananya Sarkar, Rasmi Mohan T, Sonali Tadge, and Tejaswini Somnath – are all pursuing Ph.Ds from IISc Bengaluru in areas aligning with the Sustainable Development Goals.
Quality primary health care is almost non-existent navhindtimes.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from navhindtimes.in Daily Mail and Mail on Sunday newspapers.
In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab.
<p style="text-align:start">In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab. These and other results of the analyses are presented as a proffered paper (Abstract LBA48) at the European Society of Medical Oncology (ESMO) Congress 2023 in Madrid, Spain, on Monday, October 23, by Sapna P. Patel, MD, chair of the SWOG melanoma committee and associate professor of melanoma medical oncology at the University of Texas MD Anderson Cancer Center.</p>
Over 50% Major Response to Pembrolizumab in Melanoma Trial miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.